172 related articles for article (PubMed ID: 22526213)
21. [Congenital toxoplasmosis].
Padelt H
Z Arztl Fortbild (Jena); 1982 Sep; 76(18):828-31. PubMed ID: 6758380
[No Abstract] [Full Text] [Related]
22. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
[TBL] [Abstract][Full Text] [Related]
23. Delayed onset of severe neonatal toxoplasmosis.
Al-Hamod D; Vauloup C; Goulet M; Zupan-Simunek V; Castel C; Boileau P
J Perinatol; 2010 Mar; 30(3):231-2. PubMed ID: 20182429
[TBL] [Abstract][Full Text] [Related]
24. Bilateral neuroretinitis in a 6-year-old boy with acquired toxoplasmosis.
Perrotta S; Nobili B; Grassia C; Sebastiani A; Parmeggiani F; Costagliola C
Arch Ophthalmol; 2003 Oct; 121(10):1493-6. PubMed ID: 14557195
[No Abstract] [Full Text] [Related]
25. IgM ELISA follow-up of spiramycin treatment for toxoplasmosis: should the drug be prescribed in India?
Singh S
J Assoc Physicians India; 1992 Feb; 40(2):140. PubMed ID: 1629136
[No Abstract] [Full Text] [Related]
26. Use of polymerase chain reaction (PCR) in the diagnosis of congenital toxoplasmosis.
Loveridge-Easther C; Yardley AM; Breidenstein B
J AAPOS; 2018 Jun; 22(3):239-240. PubMed ID: 29604343
[TBL] [Abstract][Full Text] [Related]
27. Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial.
Mandelbrot L; Kieffer F; Sitta R; Laurichesse-Delmas H; Winer N; Mesnard L; Berrebi A; Le Bouar G; Bory JP; Cordier AG; Ville Y; Perrotin F; Jouannic JM; Biquard F; d'Ercole C; Houfflin-Debarge V; Villena I; Thiébaut R;
Am J Obstet Gynecol; 2018 Oct; 219(4):386.e1-386.e9. PubMed ID: 29870736
[TBL] [Abstract][Full Text] [Related]
28. [Congenital toxoplasmosis following infection occurring late in pregnancy].
Ben Abdallah R; Siala E; Maatoug R; Souissi O; Aoun K; Bouratbine A
Arch Pediatr; 2011 Jul; 18(7):758-60. PubMed ID: 21632221
[TBL] [Abstract][Full Text] [Related]
29. [Letter: Significance of Toxoplasma infections for public health].
Koppe JG
Ned Tijdschr Geneeskd; 1975 Sep; 119(38):1477. PubMed ID: 1165816
[No Abstract] [Full Text] [Related]
30. Toxoplasmosis transmitted to a newborn from the mother infected 20 years earlier.
Silveira C; Ferreira R; Muccioli C; Nussenblatt R; Belfort R
Am J Ophthalmol; 2003 Aug; 136(2):370-1. PubMed ID: 12888070
[TBL] [Abstract][Full Text] [Related]
31. Treatment of infants with congenital toxoplasmosis: tolerability and plasma concentrations of sulfadiazine and pyrimethamine.
Schmidt DR; Hogh B; Andersen O; Hansen SH; Dalhoff K; Petersen E
Eur J Pediatr; 2006 Jan; 165(1):19-25. PubMed ID: 16133245
[TBL] [Abstract][Full Text] [Related]
32. Congenital toxoplasmosis from an HIV-infected woman as a result of reactivation.
Bachmeyer C; Mouchnino G; Thulliez P; Blum L
J Infect; 2006 Feb; 52(2):e55-7. PubMed ID: 16043225
[TBL] [Abstract][Full Text] [Related]
33. Prevention of congenital toxoplasmosis.
Foulon W; Naessens A; Ho-Yen D
J Perinat Med; 2000; 28(5):337-45. PubMed ID: 11125923
[TBL] [Abstract][Full Text] [Related]
34. Toxoplasmosis: diagnosis, treatment, and prevention in congenitally exposed infants.
Kaye A
J Pediatr Health Care; 2011; 25(6):355-64. PubMed ID: 22018426
[TBL] [Abstract][Full Text] [Related]
35. Cytologic identification of Toxoplasma gondii from subretinal aspirate.
Adán A; Sole M; Mateo C; Jean AS; Alforja S
Acta Ophthalmol; 2012 Jun; 90(4):392-3. PubMed ID: 20456249
[No Abstract] [Full Text] [Related]
36. Toxoplasma seropositivity and depression: a case report.
Kar N; Misra B
BMC Psychiatry; 2004 Feb; 4():1. PubMed ID: 15018628
[TBL] [Abstract][Full Text] [Related]
37. Congenital toxoplasmosis: value of prenatal treatment with pyrimethamine-sulfadoxine combination.
Villena I; Quereux C; Pinon JM
Prenat Diagn; 1998 Jul; 18(7):754-6. PubMed ID: 9706662
[No Abstract] [Full Text] [Related]
38. Evaluation of IgG anti-toxoplasma avidity and polymerase chain reaction in the postnatal diagnosis of congenital toxoplasmosis.
Torres E; Rivera R; Cardona N; Sanchez V; Lora F; Gómez-Marín JE
Pediatr Infect Dis J; 2013 Jun; 32(6):693-5. PubMed ID: 23348817
[TBL] [Abstract][Full Text] [Related]
39. Congenital toxoplasmosis, later relapses and treatment.
Koppe JG; Meenken C
Acta Paediatr; 1999 Jun; 88(6):586-8. PubMed ID: 10419236
[No Abstract] [Full Text] [Related]
40. Recurrent seizures during acute acquired toxoplasmosis in an immunocompetent traveller returning from Africa.
Beltrame A; Venturini S; Crichiutti G; Meroni V; Buonfrate D; Bassetti M
Infection; 2016 Apr; 44(2):259-62. PubMed ID: 26168861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
